Article Details

FDA boosts Antengene pancreatic cancer treatment - Labiotech.eu

Retrieved on: 2022-09-19 09:13:35

Tags for this article:

Click the tags to see associated articles and topics

FDA boosts Antengene pancreatic cancer treatment - Labiotech.eu. View article details on hiswai:

Excerpt

Biopharma company Antengene Corporation Limited says ATG-101, the company's in-house developed novel PD-L1/4-1BB bispecific antibody, ...

Article found on: www.labiotech.eu

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up